Speaker Profile

Prof. Jeffrey V. Lazarus

Prof. Jeffrey V. Lazarus

Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona

<p>Prof Lazarus is head of the health systems team at the Barcelona Institute for Global Health (ISGlobal) and an Associate Professor at the Faculty of Medicine, University of Barcelona. In 2020, he was appointed a senior scholar CUNY Graduate School of Public health, where he leads the global COVID-19 vaccine hesitancy studies. He is Vice-Chairman of the board of the EASL International Liver Foundation, co-chair of the HIV Outcomes Coalition and a member of the Public Health and Policy Committee of the European Association for the Study of the Liver. He is the author of more than 250 publications including lead author of NAFLD: a consensus statement and the expert recommendation “Defining comprehensive models of care for NAFLD” (Nature Reviews GastroHep 2021), COVID-SCORE (Nature Medicine and PLOS ONE, 2020), The Lancet HIV series HIV outcomes beyond viral suppression (2019) and a working group chair of the EASL-Lancet Liver Commission (2021). He is co-chair of Innovations in NAFLD Care Workshop 2022 and in 2020, he joined The Lancet COVID-19 Commission public health taskforce and has been advising governments, NGOs and WHO, as well as frequently appearing in the media to address pressing issues about the pandemic. Prof Lazarus is an editorial board member of the International Journal of Drug Policy, HIV Medicine and the Journal of Hepatology. Previously, he worked for 11 years at WHO Europe and 3 at the Global Fund as well as founding director of Health Systems Global and board chair of the foundation AFEW International.</p>


Pan-society Presentation of NAFLD Nomenclature Consensus Process

Date: Sunday, November 6th

Time: 4:00 - 6:00 PM EST